155 related articles for article (PubMed ID: 30345820)
1. Ragweed allergy immunotherapy tablet MK-3641 (Ragwitek®) for the treatment of allergic rhinitis.
Nelson HS
Expert Rev Clin Immunol; 2018 Dec; 14(12):1003-1011. PubMed ID: 30345820
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.
Creticos PS; Schroeder JT; Hamilton RG; Balcer-Whaley SL; Khattignavong AP; Lindblad R; Li H; Coffman R; Seyfert V; Eiden JJ; Broide D;
N Engl J Med; 2006 Oct; 355(14):1445-55. PubMed ID: 17021320
[TBL] [Abstract][Full Text] [Related]
3. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.
Didier A; Malling HJ; Worm M; Horak F; Jäger S; Montagut A; André C; de Beaumont O; Melac M
J Allergy Clin Immunol; 2007 Dec; 120(6):1338-45. PubMed ID: 17935764
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis.
Wahn U; Tabar A; Kuna P; Halken S; Montagut A; de Beaumont O; Le Gall M;
J Allergy Clin Immunol; 2009 Jan; 123(1):160-166.e3. PubMed ID: 19046761
[TBL] [Abstract][Full Text] [Related]
5. Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis.
Bowen T; Greenbaum J; Charbonneau Y; Hebert J; Filderman R; Sussman G; Del Carpio J; Gold M; Keith P; Moote W; Cecchetto S; Cecchetto O; Sharp D; Broutin O; André C
Ann Allergy Asthma Immunol; 2004 Nov; 93(5):425-30. PubMed ID: 15562880
[TBL] [Abstract][Full Text] [Related]
6. A double-blind placebo-controlled evaluation of sublingual immunotherapy with a standardized ragweed extract in patients with seasonal rhinitis. Evidence for a dose-response relationship.
André C; Perrin-Fayolle M; Grosclaude M; Couturier P; Basset D; Cornillon J; Piperno D; Girodet B; Sanchez R; Vallon C; Bellier P; Nasr M
Int Arch Allergy Immunol; 2003 Jun; 131(2):111-8. PubMed ID: 12811019
[TBL] [Abstract][Full Text] [Related]
7. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy increases CD4+CD25+ T cells in the nasal mucosa of subjects with allergic rhinitis.
Asai K; Foley SC; Sumi Y; Yamauchi Y; Takeda N; Desrosiers M; Lavigne F; Hamid Q
Allergol Int; 2008 Dec; 57(4):377-81. PubMed ID: 18797179
[TBL] [Abstract][Full Text] [Related]
8. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen.
Skoner D; Gentile D; Bush R; Fasano MB; McLaughlin A; Esch RE
J Allergy Clin Immunol; 2010 Mar; 125(3):660-6, 666.e1-666.e4. PubMed ID: 20153030
[TBL] [Abstract][Full Text] [Related]
9. Tolerability of sublingual versus vestibular allergy immunotherapy tablet administration: A randomized pilot study.
Simard ML; Novak N; Drolet JP; Joly MC; Nolte H; Wuestenberg E; Gagnon R
Clin Exp Allergy; 2024 Feb; 54(2):120-129. PubMed ID: 37990117
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled study.
Mirone C; Albert F; Tosi A; Mocchetti F; Mosca S; Giorgino M; Pecora S; Parmiani S; Ortolani C
Clin Exp Allergy; 2004 Sep; 34(9):1408-14. PubMed ID: 15347374
[TBL] [Abstract][Full Text] [Related]
11. Factors that affect the allergic rhinitis response to ragweed allergen exposure.
Ellis AK; Ratz JD; Day AG; Day JH
Ann Allergy Asthma Immunol; 2010 Apr; 104(4):293-8. PubMed ID: 20408338
[TBL] [Abstract][Full Text] [Related]
12. Oralair Birch, a recombinant major birch pollen allergen tablet for sublingual immunotherapy of allergic rhinitis caused by birch pollen.
Larenas-Linnemann D
Curr Opin Investig Drugs; 2010 May; 11(5):586-96. PubMed ID: 20419605
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of non-grass pollens respiratory allergies in Italy and effects of specific sublingual immunotherapy: The Rainbow Trial, a multicentre 3-year prospective observational study.
Milani M; Pecora S;
Eur Ann Allergy Clin Immunol; 2011 Aug; 43(4):111-6. PubMed ID: 21980798
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of IgE-binding to Art v 1, Art v 4 and Amb a 1 in mugwort-allergic patients.
Oberhuber C; Ma Y; Wopfner N; Gadermaier G; Dedic A; Niggemann B; Maderegger B; Gruber P; Ferreira F; Scheiner O; Hoffmann-Sommergruber K
Int Arch Allergy Immunol; 2008; 145(2):94-101. PubMed ID: 17823540
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactivity profile of peripheral blood mononuclear cells from patients with ragweed-induced allergic rhinitis.
Sun J; Wong B; Cundall M; Goncharova S; Conway M; Dalrymple A; Coyle AJ; Waserman S; Jordana M
Clin Exp Allergy; 2007 Jun; 37(6):901-8. PubMed ID: 17517104
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.
Bufe A; Eberle P; Franke-Beckmann E; Funck J; Kimmig M; Klimek L; Knecht R; Stephan V; Tholstrup B; Weisshaar C; Kaiser F
J Allergy Clin Immunol; 2009 Jan; 123(1):167-173.e7. PubMed ID: 19130937
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of immunotherapy to ragweed antigen tested by controlled antigen exposure.
Donovan JP; Buckeridge DL; Briscoe MP; Clark RH; Day JH
Ann Allergy Asthma Immunol; 1996 Jul; 77(1):74-80. PubMed ID: 8705641
[TBL] [Abstract][Full Text] [Related]
18. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.
Tulic MK; Fiset PO; Christodoulopoulos P; Vaillancourt P; Desrosiers M; Lavigne F; Eiden J; Hamid Q
J Allergy Clin Immunol; 2004 Feb; 113(2):235-41. PubMed ID: 14767435
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets.
Malling HJ; Lund L; Ipsen H; Poulsen L
J Investig Allergol Clin Immunol; 2006; 16(3):162-8. PubMed ID: 16784009
[TBL] [Abstract][Full Text] [Related]
20. Array-based profiling of ragweed and mugwort pollen allergens.
Gadermaier G; Wopfner N; Wallner M; Egger M; Didierlaurent A; Regl G; Aberger F; Lang R; Ferreira F; Hawranek T
Allergy; 2008 Nov; 63(11):1543-9. PubMed ID: 18925891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
